United States Healthcare Equipment & Supplies

Akoya Biosciences Inc (AKYA)

Track

Track

Ticker: AKYA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Akoya Biosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.6
McKelligon Brian President and CEO Executive Director
Transaction date
Planned sale
Price
388.72
Quantity 12,403 +47.0%
Value US$3,223,082
0.6
BRIAN M MCKELLIGON Officer; Director Executive Director
Transaction date
Proposed sale
Price
495.06
Quantity 3,097
Value US$212,562
0.6
McKelligon Brian President and CEO Executive Director
Transaction date
Planned sale
Price
477.88
Quantity 97,613 +3.5%
Value US$4,147,910
0.6
BRIAN M MCKELLIGON Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.01
Quantity 7,500
Value US$15,064
0.6
McKelligon Brian President and CEO Executive Director
Transaction date
Planned sale
Price
4.97
Quantity 7,500 -3.1%
Value US$37,243
0.6
BRIAN M MCKELLIGON Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.97
Quantity 7,500
Value US$37,243
0.6
McKelligon Brian President and CEO Executive Director
Transaction date
Planned sale
Price
4.94
Quantity 7,500 -3.2%
Value US$37,035
0.6
BRIAN M MCKELLIGON Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.94
Quantity 7,500
Value US$37,041
0.6
McKelligon Brian President and CEO Executive Director
Transaction date
Planned sale
Price
4.48
Quantity 7,500 -4.7%
Value US$33,566
0.6
BRIAN M MCKELLIGON Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.48
Quantity 7,500
Value US$33,566
0.6
McKelligon Brian President and CEO Executive Director
Transaction date
Planned sale
Price
4.25
Quantity 7,500 -4.7%
Value US$31,871
0.6
BRIAN M MCKELLIGON Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.25
Quantity 7,500
Value US$31,871
0.6
McKelligon Brian President and CEO Executive Director
Transaction date
Planned sale
Price
4.39
Quantity 7,500 -4.7%
Value US$32,901
0.6
BRIAN M MCKELLIGON Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.39
Quantity 7,500
Value US$32,901
0.8
Pla Frederic Chief Operating Officer Officer
Transaction date
Purchase
Price
4.60
Quantity 7,000 +53.8%
Value US$32,200
0.8
Pla Frederic Chief Operating Officer Officer
Transaction date
Purchase
Price
4.60
Quantity 13,000 +inf%
Value US$59,814
Moy Marilee Officer Officer
Transaction date
Proposed sale
Price
7.18
Quantity 10,000
Value US$71,750
Moy Marilee Officer Officer
Transaction date
Proposed sale
Price
20.97
Quantity 18,553
Value US$388,977
3.2
DRISCOLL JOSEPH Officer Officer
Transaction date
Proposed sale
Price
8.00
Quantity 20,000
Value US$160,000
3.2
DRISCOLL JOSEPH Officer Officer
Transaction date
Proposed sale
Price
7.79
Quantity 22,962
Value US$178,773
3.2
DRISCOLL JOSEPH Officer Officer
Transaction date
Proposed sale
Price
6.46
Quantity 10,000
Value US$64,571
2.5
SHEPLER ROBERT G Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 120,000 +48.1%
Value US$600,000
1.6
Ek John Frederick CFO Officer
Transaction date
Purchase
Price
5.00
Quantity 20,000 +inf%
Value US$100,000
1.6
Winkler Matthew Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 203,388 +26.0%
Value US$1,016,940
1.6
LAI GOLDMAN MYLA Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 20,000 +inf%
Value US$100,000
2.1
Raffin Thomas A. Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 1,803,373 +12.8%
Value US$9,016,865
2.1
Raffin Thomas A. Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 196,627 +12.8%
Value US$983,135
2.1
Raffin Thomas A. Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 20,000 +9.3%
Value US$100,000
2.2
Mendel Scott Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 20,000 +235.3%
Value US$100,000
3.2
DRISCOLL JOSEPH Officer Officer
Transaction date
Proposed sale
Price
5.55
Quantity 10,000
Value US$55,500
0.6
BRIAN M MCKELLIGON Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.71
Quantity 5,000
Value US$28,537
0.6
McKelligon Brian President/CEO Executive Director
Transaction date
Planned sale
Price
5.71
Quantity 5,000 -3.2%
Value US$28,537
3.2
DRISCOLL JOSEPH Officer Officer
Transaction date
Proposed sale
Price
5.75
Quantity 10,000
Value US$57,500
3.2
DRISCOLL JOSEPH Officer Officer
Transaction date
Proposed sale
Price
6.05
Quantity 15,000
Value US$90,750
3.2
DRISCOLL JOSEPH Officer Officer
Transaction date
Proposed sale
Price
5.95
Quantity 10,000
Value US$59,500
0.6
McKelligon Brian President/CEO Executive Director
Transaction date
Planned sale
Price
9.92
Quantity 226 -0.1%
Value US$2,241
0.6
McKelligon Brian President/CEO Executive Director
Transaction date
Planned sale
Price
9.14
Quantity 4,774 -2.9%
Value US$43,610
3.2
DRISCOLL JOSEPH Chief Financial Officer Officer
Transaction date
Sale
Price
12.46
Quantity 14,574 -53.8%
Value US$181,519
3.2
DRISCOLL JOSEPH Chief Financial Officer Officer
Transaction date
Sale
Price
12.67
Quantity 10,039 -44.5%
Value US$127,187
3.7
SCHNETTLER THOMAS P Non-Executive Director
Transaction date
Sale
Price
13.03
Quantity 71,050 -2.5%
Value US$925,782
0.6
McKelligon Brian President/CEO Officer
Transaction date
Planned sale
Price
12.08
Quantity 5,000 -5.9%
Value US$60,415
3.8
Nolan Garry Ph.D. Non-Executive Director
Transaction date
Sale
Price
13.25
Quantity 1,100 -0.2%
Value US$14,575
3.8
Nolan Garry Ph.D. Non-Executive Director
Transaction date
Sale
Price
13.36
Quantity 5,000 -0.8%
Value US$66,788
3.8
Nolan Garry Ph.D. Non-Executive Director
Transaction date
Sale
Price
13.25
Quantity 300 -0.1%
Value US$3,976
3.8
Nolan Garry Ph.D. Non-Executive Director
Transaction date
Sale
Price
13.28
Quantity 600 -0.1%
Value US$7,966
3.8
Nolan Garry Ph.D. Non-Executive Director
Transaction date
Sale
Price
13.29
Quantity 20,000 -3.2%
Value US$265,858
3.8
Nolan Garry Ph.D. Non-Executive Director
Transaction date
Sale
Price
13.31
Quantity 3,810 -0.6%
Value US$50,705
3.8
Nolan Garry Ph.D. Non-Executive Director
Transaction date
Sale
Price
13.26
Quantity 8,305 -1.3%
Value US$110,084
3.8
Nolan Garry Ph.D. Non-Executive Director
Transaction date
Sale
Price
13.30
Quantity 1,800 -0.3%
Value US$23,944
3.8
Nolan Garry Ph.D. Non-Executive Director
Transaction date
Sale
Price
13.31
Quantity 22,191 -3.4%
Value US$295,338
0.6
McKelligon Brian President/CEO Officer
Transaction date
Planned sale
Price
12.83
Quantity 5,000 -5.9%
Value US$64,170
0.6
McKelligon Brian President/CEO Officer
Transaction date
Sale
Price
10.25
Quantity 5,000 -5.9%
Value US$51,260
3.8
Nolan Garry Ph.D. Non-Executive Director
Transaction date
Sale
Price
13.25
Quantity 100 -0.0%
Value US$1,325
3.8
Nolan Garry Ph.D. Non-Executive Director
Transaction date
Sale
Price
12.67
Quantity 25,000 -3.7%
Value US$316,762
1.8
Ramachandran Niro Ph.D Chief Business Officer Officer
Transaction date
Purchase
Price
13.13
Quantity 25,000 +34246.6%
Value US$328,292
1.8
Ramachandran Niro Ph.D Chief Business Officer Officer
Transaction date
Purchase
Price
12.85
Quantity 73 +inf%
Value US$938
2.2
Mendel Scott Non-Executive Director
Transaction date
Purchase
Price
13.16
Quantity 8,500 +inf%
Value US$111,860
2.5
SHEPLER ROBERT G Non-Executive Director
Transaction date
Purchase
Price
12.93
Quantity 20,000 +133.3%
Value US$258,500
2.5
SHEPLER ROBERT G Non-Executive Director
Transaction date
Purchase
Price
12.17
Quantity 15,000 +inf%
Value US$182,505
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-12 2024-06-11 PlS Planned sale
0.6
McKelligon Brian

President and CEO

Executive Director
12,403 +47.0%
388.72
US$3,223,082 		12,403 +47.0% 388.72 US$3,223,082
2024-06-11 2024-06-11 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
3,097
495.06
US$212,562 		3,097 495.06 US$212,562
2024-06-07 2024-06-06 PlS Planned sale
0.6
McKelligon Brian

President and CEO

Executive Director
97,613 +3.5%
477.88
US$4,147,910 		97,613 +3.5% 477.88 US$4,147,910
2024-06-06 2024-06-06 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
7,500
2.01
US$15,064 		7,500 2.01 US$15,064
2024-03-22 2024-03-20 PlS Planned sale
0.6
McKelligon Brian

President and CEO

Executive Director
7,500 -3.1%
4.97
US$37,243 		7,500 -3.1% 4.97 US$37,243
2024-03-20 2024-03-20 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
7,500
4.97
US$37,243 		7,500 4.97 US$37,243
2024-03-14 2024-03-13 PlS Planned sale
0.6
McKelligon Brian

President and CEO

Executive Director
7,500 -3.2%
4.94
US$37,035 		7,500 -3.2% 4.94 US$37,035
2024-03-13 2024-03-13 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
7,500
4.94
US$37,041 		7,500 4.94 US$37,041
2023-12-20 2023-12-19 PlS Planned sale
0.6
McKelligon Brian

President and CEO

Executive Director
7,500 -4.7%
4.48
US$33,566 		7,500 -4.7% 4.48 US$33,566
2023-12-19 2023-12-19 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
7,500
4.48
US$33,566 		7,500 4.48 US$33,566
2023-12-14 2023-12-12 PlS Planned sale
0.6
McKelligon Brian

President and CEO

Executive Director
7,500 -4.7%
4.25
US$31,871 		7,500 -4.7% 4.25 US$31,871
2023-12-12 2023-12-12 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
7,500
4.25
US$31,871 		7,500 4.25 US$31,871
2023-11-22 2023-11-20 PlS Planned sale
0.6
McKelligon Brian

President and CEO

Executive Director
7,500 -4.7%
4.39
US$32,901 		7,500 -4.7% 4.39 US$32,901
2023-11-20 2023-11-20 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
7,500
4.39
US$32,901 		7,500 4.39 US$32,901
2023-09-11 2023-09-07 B Purchase
0.8
Pla Frederic

Chief Operating Officer

Officer
7,000 +53.8%
4.60
US$32,200 		7,000 +53.8% 4.60 US$32,200
2023-09-11 2023-09-07 B Purchase
0.8
Pla Frederic

Chief Operating Officer

Officer
13,000 +inf%
4.60
US$59,814 		13,000 +inf% 4.60 US$59,814
2023-07-13 2023-07-13 PrS Proposed sale
Moy Marilee

Officer

Officer
10,000
7.18
US$71,750 		10,000 7.18 US$71,750
2023-07-12 2023-07-12 PrS Proposed sale
Moy Marilee

Officer

Officer
18,553
20.97
US$388,977 		18,553 20.97 US$388,977
2023-06-15 2023-06-15 PrS Proposed sale
3.2
DRISCOLL JOSEPH

Officer

Officer
20,000
8.00
US$160,000 		20,000 8.00 US$160,000
2023-06-14 2023-06-14 PrS Proposed sale
3.2
DRISCOLL JOSEPH

Officer

Officer
22,962
7.79
US$178,773 		22,962 7.79 US$178,773
2023-06-13 2023-06-13 PrS Proposed sale
3.2
DRISCOLL JOSEPH

Officer

Officer
10,000
6.46
US$64,571 		10,000 6.46 US$64,571
2023-06-12 2023-06-12 B Purchase
2.5
SHEPLER ROBERT G
Non-Executive Director
120,000 +48.1%
5.00
US$600,000 		120,000 +48.1% 5.00 US$600,000
2023-06-12 2023-06-12 B Purchase
1.6
Ek John Frederick

CFO

Officer
20,000 +inf%
5.00
US$100,000 		20,000 +inf% 5.00 US$100,000
2023-06-12 2023-06-12 B Purchase
1.6
Winkler Matthew
Non-Executive Director
203,388 +26.0%
5.00
US$1,016,940 		203,388 +26.0% 5.00 US$1,016,940
2023-06-12 2023-06-12 B Purchase
1.6
LAI GOLDMAN MYLA
Non-Executive Director
20,000 +inf%
5.00
US$100,000 		20,000 +inf% 5.00 US$100,000
2023-06-12 2023-06-12 B Purchase
2.1
Raffin Thomas A.
Non-Executive Director
1,803,373 +12.8%
5.00
US$9,016,865 		1,803,373 +12.8% 5.00 US$9,016,865
2023-06-12 2023-06-12 B Purchase
2.1
Raffin Thomas A.
Non-Executive Director
196,627 +12.8%
5.00
US$983,135 		196,627 +12.8% 5.00 US$983,135
2023-06-12 2023-06-12 B Purchase
2.1
Raffin Thomas A.
Non-Executive Director
20,000 +9.3%
5.00
US$100,000 		20,000 +9.3% 5.00 US$100,000
2023-06-12 2023-06-12 B Purchase
2.2
Mendel Scott
Non-Executive Director
20,000 +235.3%
5.00
US$100,000 		20,000 +235.3% 5.00 US$100,000
2023-06-06 2023-06-06 PrS Proposed sale
3.2
DRISCOLL JOSEPH

Officer

Officer
10,000
5.55
US$55,500 		10,000 5.55 US$55,500
2023-06-06 2023-06-06 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
5,000
5.71
US$28,537 		5,000 5.71 US$28,537
2023-06-06 2023-06-06 PlS Planned sale
0.6
McKelligon Brian

President/CEO

Executive Director
5,000 -3.2%
5.71
US$28,537 		5,000 -3.2% 5.71 US$28,537
2023-05-31 2023-05-31 PrS Proposed sale
3.2
DRISCOLL JOSEPH

Officer

Officer
10,000
5.75
US$57,500 		10,000 5.75 US$57,500
2023-05-24 2023-05-24 PrS Proposed sale
3.2
DRISCOLL JOSEPH

Officer

Officer
15,000
6.05
US$90,750 		15,000 6.05 US$90,750
2023-05-17 2023-05-17 PrS Proposed sale
3.2
DRISCOLL JOSEPH

Officer

Officer
10,000
5.95
US$59,500 		10,000 5.95 US$59,500
2023-03-16 2023-03-14 PlS Planned sale
0.6
McKelligon Brian

President/CEO

Executive Director
226 -0.1%
9.92
US$2,241 		226 -0.1% 9.92 US$2,241
2023-03-16 2023-03-14 PlS Planned sale
0.6
McKelligon Brian

President/CEO

Executive Director
4,774 -2.9%
9.14
US$43,610 		4,774 -2.9% 9.14 US$43,610
2022-12-16 2022-12-14 S Sale
3.2
DRISCOLL JOSEPH

Chief Financial Officer

Officer
14,574 -53.8%
12.46
US$181,519 		14,574 -53.8% 12.46 US$181,519
2022-12-16 2022-12-14 S Sale
3.2
DRISCOLL JOSEPH

Chief Financial Officer

Officer
10,039 -44.5%
12.67
US$127,187 		10,039 -44.5% 12.67 US$127,187
2022-12-20 2022-12-13 S Sale
3.7
SCHNETTLER THOMAS P
Non-Executive Director
71,050 -2.5%
13.03
US$925,782 		71,050 -2.5% 13.03 US$925,782
2022-12-08 2022-12-06 PlS Planned sale
0.6
McKelligon Brian

President/CEO

Officer
5,000 -5.9%
12.08
US$60,415 		5,000 -5.9% 12.08 US$60,415
2022-12-06 2022-12-02 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
1,100 -0.2%
13.25
US$14,575 		1,100 -0.2% 13.25 US$14,575
2022-12-02 2022-12-01 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
5,000 -0.8%
13.36
US$66,788 		5,000 -0.8% 13.36 US$66,788
2022-11-17 2022-11-16 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
300 -0.1%
13.25
US$3,976 		300 -0.1% 13.25 US$3,976
2022-11-14 2022-11-14 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
600 -0.1%
13.28
US$7,966 		600 -0.1% 13.28 US$7,966
2022-11-14 2022-11-11 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
20,000 -3.2%
13.29
US$265,858 		20,000 -3.2% 13.29 US$265,858
2022-11-14 2022-11-10 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
3,810 -0.6%
13.31
US$50,705 		3,810 -0.6% 13.31 US$50,705
2022-09-16 2022-09-14 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
8,305 -1.3%
13.26
US$110,084 		8,305 -1.3% 13.26 US$110,084
2022-09-13 2022-09-12 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
1,800 -0.3%
13.30
US$23,944 		1,800 -0.3% 13.30 US$23,944
2022-09-13 2022-09-09 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
22,191 -3.4%
13.31
US$295,338 		22,191 -3.4% 13.31 US$295,338
2022-09-09 2022-09-07 PlS Planned sale
0.6
McKelligon Brian

President/CEO

Officer
5,000 -5.9%
12.83
US$64,170 		5,000 -5.9% 12.83 US$64,170
2022-06-17 2022-06-15 S Sale
0.6
McKelligon Brian

President/CEO

Officer
5,000 -5.9%
10.25
US$51,260 		5,000 -5.9% 10.25 US$51,260
2022-12-15 2021-12-13 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
100 -0.0%
13.25
US$1,325 		100 -0.0% 13.25 US$1,325
2021-12-13 2021-12-09 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
25,000 -3.7%
12.67
US$316,762 		25,000 -3.7% 12.67 US$316,762
2021-11-22 2021-11-22 B Purchase
1.8
Ramachandran Niro Ph.D

Chief Business Officer

Officer
25,000 +34246.6%
13.13
US$328,292 		25,000 +34246.6% 13.13 US$328,292
2021-11-22 2021-11-19 B Purchase
1.8
Ramachandran Niro Ph.D

Chief Business Officer

Officer
73 +inf%
12.85
US$938 		73 +inf% 12.85 US$938
2021-11-19 2021-11-19 B Purchase
2.2
Mendel Scott
Non-Executive Director
8,500 +inf%
13.16
US$111,860 		8,500 +inf% 13.16 US$111,860
2021-11-18 2021-11-18 B Purchase
2.5
SHEPLER ROBERT G
Non-Executive Director
20,000 +133.3%
12.93
US$258,500 		20,000 +133.3% 12.93 US$258,500
2021-11-18 2021-11-18 B Purchase
2.5
SHEPLER ROBERT G
Non-Executive Director
15,000 +inf%
12.17
US$182,505 		15,000 +inf% 12.17 US$182,505
Explore more

More insider trading research around Akoya Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America